
    
      This clinical trial is conducted with a randomized, open-label, single-dose, and cross over
      study designs. Investigators will compare the pharmacokinetic parameters of test drug(single
      oral dose, single administration) with pharmacokinetic parameters of comparator 1 and
      2(combined administration, single oral dose).
    
  